DOCSLIB.ORG

2012/037456 Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date - 22 March 2012 (22.03.2012) 2012/037456 Al (51) International Patent Classification: (74) Agents: RESNICK, David, S. et al; Nixon Peabody CI2Q 1/68 (2006.01) LLP, 100 Summer Street, Boston, MA 021 10 (US). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/US201 1/05 193 1 kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (22) International Filing Date: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, 16 September 201 1 (16.09.201 1) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (25) Filing Language: English HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, (26) Publication Language: English ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (30) Priority Data: NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, 61/384,030 17 September 2010 (17.09.2010) US RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, 61/429,965 5 January 201 1 (05.01 .201 1) US TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant (for all designated States except US): PRESI¬ DENT AND FELLOWS OF HARVARD COLLEGE (84) Designated States (unless otherwise indicated, for every [US/US]; 17 Quincy Street, Cambridge, MA 02138 (US). kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, (72) Inventors; and ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, (75) Inventors/ Applicants (for US only): EGGAN, Kevin, C. TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, [US/US]; 181 Essex Street #E402, Boston, MA 021 11 EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, ΓΓ, LT, LU, (US). MEISSNER, Alexander [DE/US]; 6 Fourth Street LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, Place, Apt. 3, Cambridge, MA 02141 (US). BOCK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, Christoph [DE/US]; 5 15 Green Street, Cambridge, MA GW, ML, MR, NE, SN, TD, TG). 02139 (US). KISKINIS, Evangelos [GR/US]; 504 Bea Published: con Street #56, Boston, MA 021 15 (US). VERSTAP- PEN, Griet, Annie, Frans [BE/BE]; 16/1 Ridder van — with international search report (Art. 21(3)) Ranstlei, B-2640 Mortsel (BE). (54) Title: FUNCTIONAL GENOMICS ASSAY FOR CHARACTERIZING PLURIPOTENT STEM CELL UTILITY AND SAFETY CD C FIG. 22B (57) Abstract: The present invention generally relates set of reference data or "scorecard" for a pluripotent stem cell, and meth © ods, systems and kits to generate a scorecard for predicting the functionality and suitability of a pluripotent stem cell line for a de sired use. In some aspects, a method for generating a scorecard comprises using at least 2 stem cell assays selected from: epigenet- o ic profiling, differentiation assay and gene expression assay to predict the functionality and suitability of a pluripotent stem cell line for a desired use. In some embodiments, the scorecard reference data can be compared with the pluripotent stem cells data to effectively and accurately predict the utility of the pluripotent stem cell for a given application, as well as any to identify specific o characteristics of the pluripotent stem cell line to determine their suitability for downstream applications, such as for example, their suitability for therapeutic use, drug screening and toxicity assays, differentiation into a desired cell lineage, and the like. FUNCTIONAL GENOMICS ASSAY FOR CHARACTERIZING PLURIPOTENT STEM CELL UTILITY AND SAFETY CROSS REFERENCE TO RELATED APPLICATIONS [001] This application claims priority under 35 U.S.C. 119(e) of U.S. Provisional Patent Application Serial No: 61/384,030 filed on September 17, 2010, and provisional application 61/429,965 filed on January 5, 201 1, the contents of which are incorporated herein by reference in their entirety. FIELD OF THE INVENTION [002] The present invention relates to method for characterizing, such as characterizing by high throughput methods, stem cells, and for methods and compositions for standardizing and optimizing the selection of pluripotent cell lines for disease modeling, studying stem cell population and their use for therapeutic treatment of diseases. GOVERNMENT SUPPORT [003] This invention was made in part, with government support under NIH Roadmap Initiative on Epigenomics, Grant Number U01ES017155 awarded by National Institutes of Health. The Government of the U.S. has certain rights in the invention. REFERENCES TO TABLES [004] This application includes as part of the originally filed subject matter three compact discs, labeled "Copy 1" and "Copy 2," and "Copy 3" each disc containing eleven (11) text files. Each of the compact discs ("Copy 1", "Copy 2" and "Copy 3") includes eleven (11) text files for ten separate lengthy tables, which are named "002806-06774 1-P2_TABLE 3.txt" (9,919 KB, created 1/7/2011), "002806- 06774 1-P2_TABLE 4.txt" (19,381 KB, created 1/7/2011), "002806-06774 1-P2_TABLE 5.txt" (10,006 KB, created 1/7/2011), "002806-06774 1-P2_TABLE 8.txt" (98 KB, created 1/7/2011), "002806-067741- P2_TABLE 10.txt" (180 KB, created 1/7/2011), "002806-067741 -P2_TABLE 12A.txt" (160 KB, created 1/7/2011); "002806-067741 -P2_TABLE 12B.txt" (160 KB, created 1/7/2011); "002806-067741- P2_TABLE 12C.txt" (31 KB, created 1/7/2011), 002806-067741 -P2_TABLE 13A.txt (25KB, created 1/7/2011), 002806-067741-P2_TABLE 13B.txt (28KB, created 1/7/2011), 002806-06774 1-P2_TABLE 14.txt (10KB, created 1/7/2011). The machine format of each compact disc ("Copy 1", "Copy 2" and "Copy 3") is IBM-PC and the operating system of each compact disc is MS-Windows. The contents of the compact discs labeled "Copy 1" and "Copy 2" and "Copy 3" are hereby incorporated by reference herein in their entireties. LENGTHY TABLES [005] The specification includes eleven (11) lengthy Tables; Tables 3, Table 4, Table 5, Table 8, Table 10, Table 12A, Table 12B, Table 12C, Table 13A,Table 13B and Table 14. Lengthy Table 3 is the integrated DNA methylation and gene expression data for Ensembl genes and promoter regions (defined as -5kb to +lkb surrounding the Ensembl-annotated transcription start site) and is provided herein in an electronic format on a CD, as file "002806-06774 1-P2_TABLE 3.txt". Lengthy Table 4 is the DNA methylation data for 35 cell lines and 31,929 Ensembl gene promoter regions, sorted in descending order of epigenetic variation among all ES cell lines (column BF) and is provided herein in an electronic format on a CD, as file "002806-067741-P2_TABLE 4.txt". Lengthy Table 5 is the Gene expression data for 35 cell lines and 15,079 Ensembl genes, sorted in descending order of transcription variation among all ES cell lines (column BG) and is provided herein in an electronic format on a CD, as file "002806-067741- P2_TABLE 5.txt". Lengthy Table 8 is a table of the details of the individual measurements contributing to the lineage scorecard prediction and is provided herein in an electronic format on a CD, as file "002806- 06774 1-P2_TABLE 8.txt". Lengthy Table 10 is a table of the Gene expression data used for construction and validation of the lineage scorecard and is provided herein in an electronic format on a CD, as file "002806-06774 1-P2_TABLE 10.txt". Lengthy Tables Table 12A, 12B and 12C are tables of the list of target genes for use in the score card, or assays and methods, with Table 12A showing, genes listed in descending order of priority which have been identified based on the variability in the reference set of DNA methylation variation among human pluripotent cell lines and Table 12B showing genes listed in descending order of priority that have been identified based on the variability in the reference set of gene expression variation among human pluripotent cell lines, and Table 12C showing genes are listed in descending order of priority and have been retrieved from the literature using an statistical ranking and information retrieval scheme, where genes from Table 12A, and/or Table 12B and/or Table 12C can be used for determining the score card and is provided herein in an electronic format on a CD, as files "002806-067741-P2_TABLE 12A.txt", "002806-06774 1-P2_TABLE 12B.txt" and "002806-067741- P2_TABLE 12C.txt" respectively. Lengthty Tables 13A and 13B are tables of an alternative list of target genes listed as "included genes" which can be used for DNA methylation and gene expression measurement for determining the score card and lineage scorecard and is provided herein in an electronic format on a CD, as files "002806-067741-P2_TABLE 13A.txt" and "002806-06774 1-P2_TABLE 13B.txt" respectively. Lengthty Tables 14 is a table of an alternative list of target genes which are subgroup of genes of Table 13A which can be used for DNA methylation and gene expression measurement for determining the score card and lineage scorecard and is provided herein in an electronic format on a CD, as files "002806-067741-P2_TABLE 14.txt" Table 3, Tables 4, Table 5, Table 8, Table 10 and Tables 12A-12C, provided herein in an electronic format on a CD, as files "002806-067741- P2_TABLE 3.txt"; "002806-06774 1-P2_TABLE 4.txt"; "002806-067741-P2_TABLE 5.txt"; "002806- 067741-P2_TABLE 8.txt" ; "002806-067741-P2_TABLE 10.txt", "002806-067741-P2_TABLE 12A.txt", "002806-067741-P2_TABLE 12B.txt", "002806-06774 1-P2_TABLE 12C.txt", "002806-067741- P2_TABLE 13A.txt", "002806-06774 1-P2_TABLE 13B.txt" and "002806-06774 1-P2_TABLE 14.txt" respectively are incorporated herein by reference in their entirety.
Recommended publications
  • The Rise and Fall of the Bovine Corpus Luteum

    The Rise and Fall of the Bovine Corpus Luteum

    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-6-2017 The Rise and Fall of the Bovine Corpus Luteum Heather Talbott University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Biochemistry Commons, Molecular Biology Commons, and the Obstetrics and Gynecology Commons Recommended Citation Talbott, Heather, "The Rise and Fall of the Bovine Corpus Luteum" (2017). Theses & Dissertations. 207. https://digitalcommons.unmc.edu/etd/207 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. THE RISE AND FALL OF THE BOVINE CORPUS LUTEUM by Heather Talbott A DISSERTATION Presented to the Faculty of the University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Biochemistry and Molecular Biology Graduate Program Under the Supervision of Professor John S. Davis University of Nebraska Medical Center Omaha, Nebraska May, 2017 Supervisory Committee: Carol A. Casey, Ph.D. Andrea S. Cupp, Ph.D. Parmender P. Mehta, Ph.D. Justin L. Mott, Ph.D. i ACKNOWLEDGEMENTS This dissertation was supported by the Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) Pre-doctoral award; University of Nebraska Medical Center Graduate Student Assistantship; University of Nebraska Medical Center Exceptional Incoming Graduate Student Award; the VA Nebraska-Western Iowa Health Care System Department of Veterans Affairs; and The Olson Center for Women’s Health, Department of Obstetrics and Gynecology, Nebraska Medical Center.
  • Functional Annotation of Exon Skipping Event in Human Pora Kim1,*,†, Mengyuan Yang1,†,Keyiya2, Weiling Zhao1 and Xiaobo Zhou1,3,4,*

    Functional Annotation of Exon Skipping Event in Human Pora Kim1,*,†, Mengyuan Yang1,†,Keyiya2, Weiling Zhao1 and Xiaobo Zhou1,3,4,*

    D896–D907 Nucleic Acids Research, 2020, Vol. 48, Database issue Published online 23 October 2019 doi: 10.1093/nar/gkz917 ExonSkipDB: functional annotation of exon skipping event in human Pora Kim1,*,†, Mengyuan Yang1,†,KeYiya2, Weiling Zhao1 and Xiaobo Zhou1,3,4,* 1School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA, 2College of Electronics and Information Engineering, Tongji University, Shanghai, China, 3McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA and 4School of Dentistry, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA Received August 13, 2019; Revised September 21, 2019; Editorial Decision October 03, 2019; Accepted October 03, 2019 ABSTRACT been used as therapeutic targets (3–8). For example, MET has lost the binding site of E3 ubiquitin ligase CBL through Exon skipping (ES) is reported to be the most com- exon 14 skipping event (9), resulting in an enhanced expres- mon alternative splicing event due to loss of func- sion level of MET. MET amplification drives the prolifera- tional domains/sites or shifting of the open read- tion of tumor cells. Multiple tyrosine kinase inhibitors, such ing frame (ORF), leading to a variety of human dis- as crizotinib, cabozantinib and capmatinib, have been used eases and considered therapeutic targets. To date, to treat patients with MET exon 14 skipping (10). Another systematic and intensive annotations of ES events example is the dystrophin gene (DMD) in Duchenne mus- based on the skipped exon units in cancer and cular dystrophy (DMD), a progressive neuromuscular dis- normal tissues are not available.
  • Novel Mutation and Three Other Sequence Variants Segregating with Phenotype at Keratoconus 13Q32 Susceptibility Locus

    Novel Mutation and Three Other Sequence Variants Segregating with Phenotype at Keratoconus 13Q32 Susceptibility Locus

    European Journal of Human Genetics (2012) 20, 389–397 & 2012 Macmillan Publishers Limited All rights reserved 1018-4813/12 www.nature.com/ejhg ARTICLE Novel mutation and three other sequence variants segregating with phenotype at keratoconus 13q32 susceptibility locus Marta Czugala1,6, Justyna A Karolak1,6, Dorota M Nowak1, Piotr Polakowski2, Jose Pitarque3, Andrea Molinari3, Malgorzata Rydzanicz1, Bassem A Bejjani4, Beatrice YJT Yue5, Jacek P Szaflik2 and Marzena Gajecka*,1 Keratoconus (KTCN), a non-inflammatory corneal disorder characterized by stromal thinning, represents a major cause of corneal transplantations. Genetic and environmental factors have a role in the etiology of this complex disease. Previously reported linkage analysis revealed that chromosomal region 13q32 is likely to contain causative gene(s) for familial KTCN. Consequently, we have chosen eight positional candidate genes in this region: MBNL1, IPO5, FARP1, RNF113B, STK24, DOCK9, ZIC5 and ZIC2, and sequenced all of them in 51 individuals from Ecuadorian KTCN families and 105 matching controls. The mutation screening identified one mutation and three sequence variants showing 100% segregation under a dominant model with KTCN phenotype in one large Ecuadorian family. These substitutions were found in three different genes: c.2262A4C (p.Gln754His) and c.720+43A4GinDOCK9; c.2377-132A4CinIPO5 and c.1053+29G4CinSTK24. PolyPhen analyses predicted that c.2262A4C (Gln754His) is possibly damaging for the protein function and structure. Our results suggest that c.2262A4C (p.Gln754His)
  • Noelia Díaz Blanco

    Noelia Díaz Blanco

    Effects of environmental factors on the gonadal transcriptome of European sea bass (Dicentrarchus labrax), juvenile growth and sex ratios Noelia Díaz Blanco Ph.D. thesis 2014 Submitted in partial fulfillment of the requirements for the Ph.D. degree from the Universitat Pompeu Fabra (UPF). This work has been carried out at the Group of Biology of Reproduction (GBR), at the Department of Renewable Marine Resources of the Institute of Marine Sciences (ICM-CSIC). Thesis supervisor: Dr. Francesc Piferrer Professor d’Investigació Institut de Ciències del Mar (ICM-CSIC) i ii A mis padres A Xavi iii iv Acknowledgements This thesis has been made possible by the support of many people who in one way or another, many times unknowingly, gave me the strength to overcome this "long and winding road". First of all, I would like to thank my supervisor, Dr. Francesc Piferrer, for his patience, guidance and wise advice throughout all this Ph.D. experience. But above all, for the trust he placed on me almost seven years ago when he offered me the opportunity to be part of his team. Thanks also for teaching me how to question always everything, for sharing with me your enthusiasm for science and for giving me the opportunity of learning from you by participating in many projects, collaborations and scientific meetings. I am also thankful to my colleagues (former and present Group of Biology of Reproduction members) for your support and encouragement throughout this journey. To the “exGBRs”, thanks for helping me with my first steps into this world. Working as an undergrad with you Dr.
  • Small-Molecule Inhibitors of Protein Acetylation and Deacetylation

    Small-Molecule Inhibitors of Protein Acetylation and Deacetylation

    Downloaded from rnajournal.cshlp.org on March 23, 2009 - Published by Cold Spring Harbor Laboratory Press Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation Andreas N. Kuhn, Maria A. van Santen, Andreas Schwienhorst, et al. RNA 2009 15: 153-175 originally published online November 24, 2008 Access the most recent version at doi:10.1261/rna.1332609 References This article cites 65 articles, 36 of which can be accessed free at: http://rnajournal.cshlp.org/content/15/1/153.full.html#ref-list-1 Email alerting Receive free email alerts when new articles cite this article - sign up in the box at the service top right corner of the article or click here To subscribe to RNA go to: http://rnajournal.cshlp.org/subscriptions Copyright © 2009 RNA Society JOBNAME: RNA 15#1 2009 PAGE: 1 OUTPUT: Tuesday December 9 15:25:03 2008 csh/RNA/175400/rna13326 Downloaded from rnajournal.cshlp.org on March 23, 2009 - Published by Cold Spring Harbor Laboratory Press Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation ANDREAS N. KUHN,1 MARIA A. VAN SANTEN,1 ANDREAS SCHWIENHORST,2 HENNING URLAUB,3 and REINHARD LU¨ HRMANN1 1Department of Cellular Biochemistry, Max Planck Institute for Biophysical Chemistry, D-37077 Go¨ttingen, Germany 2Department of Molecular Genetics and Preparative Molecular Biology, Institute for Microbiology and Genetics, D-37077 Go¨ttingen, Germany 3Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, D-37077 Go¨ttingen, Germany ABSTRACT The removal of intervening sequences from a primary RNA transcript is catalyzed by the spliceosome, a large complex consisting of five small nuclear (sn) RNAs and more than 150 proteins.
  • Biological Models of Colorectal Cancer Metastasis and Tumor Suppression

    Biological Models of Colorectal Cancer Metastasis and Tumor Suppression

    BIOLOGICAL MODELS OF COLORECTAL CANCER METASTASIS AND TUMOR SUPPRESSION PROVIDE MECHANISTIC INSIGHTS TO GUIDE PERSONALIZED CARE OF THE COLORECTAL CANCER PATIENT By Jesse Joshua Smith Dissertation Submitted to the Faculty of the Graduate School of Vanderbilt University In partial fulfillment of the requirements For the degree of DOCTOR OF PHILOSOPHY In Cell and Developmental Biology May, 2010 Nashville, Tennessee Approved: Professor R. Daniel Beauchamp Professor Robert J. Coffey Professor Mark deCaestecker Professor Ethan Lee Professor Steven K. Hanks Copyright 2010 by Jesse Joshua Smith All Rights Reserved To my grandparents, Gladys and A.L. Lyth and Juanda Ruth and J.E. Smith, fully supportive and never in doubt. To my amazing and enduring parents, Rebecca Lyth and Jesse E. Smith, Jr., always there for me. .my sure foundation. To Jeannine, Bill and Reagan for encouragement, patience, love, trust and a solid backing. To Granny George and Shawn for loving support and care. And To my beautiful wife, Kelly, My heart, soul and great love, Infinitely supportive, patient and graceful. ii ACKNOWLEDGEMENTS This work would not have been possible without the financial support of the Vanderbilt Medical Scientist Training Program through the Clinical and Translational Science Award (Clinical Investigator Track), the Society of University Surgeons-Ethicon Scholarship Fund and the Surgical Oncology T32 grant and the Vanderbilt Medical Center Section of Surgical Sciences and the Department of Surgical Oncology. I am especially indebted to Drs. R. Daniel Beauchamp, Chairman of the Section of Surgical Sciences, Dr. James R. Goldenring, Vice Chairman of Research of the Department of Surgery, Dr. Naji N.
  • Ohnologs in the Human Genome Are Dosage Balanced and Frequently Associated with Disease

    Ohnologs in the Human Genome Are Dosage Balanced and Frequently Associated with Disease

    Ohnologs in the human genome are dosage balanced and frequently associated with disease Takashi Makino1 and Aoife McLysaght2 Smurfit Institute of Genetics, University of Dublin, Trinity College, Dublin 2, Ireland Edited by Michael Freeling, University of California, Berkeley, CA, and approved April 9, 2010 (received for review December 21, 2009) About 30% of protein-coding genes in the human genome are been duplicated by WGD, subsequent loss of individual genes related through two whole genome duplication (WGD) events. would result in a dosage imbalance due to insufficient gene Although WGD is often credited with great evolutionary impor- product, thus leading to biased retention of dosage-balanced tance, the processes governing the retention of these genes and ohnologs. In fact, evidence for preferential retention of dosage- their biological significance remain unclear. One increasingly pop- balanced genes after WGD is accumulating (4, 7, 11–20). Copy ular hypothesis is that dosage balance constraints are a major number variation [copy number polymorphism (CNV)] describes determinant of duplicate gene retention. We test this hypothesis population level polymorphism of small segmental duplications and show that WGD-duplicated genes (ohnologs) have rarely and is known to directly correlate with gene expression levels (21– experienced subsequent small-scale duplication (SSD) and are also 24). Thus, CNV of dosage-balanced genes is also expected to be refractory to copy number variation (CNV) in human populations deleterious. This model predicts that retained ohnologs should be and are thus likely to be sensitive to relative quantities (i.e., they are enriched for dosage-balanced genes that are resistant to sub- dosage-balanced).
  • Mrna Editing, Processing and Quality Control in Caenorhabditis Elegans

    Mrna Editing, Processing and Quality Control in Caenorhabditis Elegans

    | WORMBOOK mRNA Editing, Processing and Quality Control in Caenorhabditis elegans Joshua A. Arribere,*,1 Hidehito Kuroyanagi,†,1 and Heather A. Hundley‡,1 *Department of MCD Biology, UC Santa Cruz, California 95064, †Laboratory of Gene Expression, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan, and ‡Medical Sciences Program, Indiana University School of Medicine-Bloomington, Indiana 47405 ABSTRACT While DNA serves as the blueprint of life, the distinct functions of each cell are determined by the dynamic expression of genes from the static genome. The amount and specific sequences of RNAs expressed in a given cell involves a number of regulated processes including RNA synthesis (transcription), processing, splicing, modification, polyadenylation, stability, translation, and degradation. As errors during mRNA production can create gene products that are deleterious to the organism, quality control mechanisms exist to survey and remove errors in mRNA expression and processing. Here, we will provide an overview of mRNA processing and quality control mechanisms that occur in Caenorhabditis elegans, with a focus on those that occur on protein-coding genes after transcription initiation. In addition, we will describe the genetic and technical approaches that have allowed studies in C. elegans to reveal important mechanistic insight into these processes. KEYWORDS Caenorhabditis elegans; splicing; RNA editing; RNA modification; polyadenylation; quality control; WormBook TABLE OF CONTENTS Abstract 531 RNA Editing and Modification 533 Adenosine-to-inosine RNA editing 533 The C. elegans A-to-I editing machinery 534 RNA editing in space and time 535 ADARs regulate the levels and fates of endogenous dsRNA 537 Are other modifications present in C.
  • Stalling of Spliceosome Assembly at Distinct Stages by Small-Molecule Inhibitors of Protein Acetylation and Deacetylation

    Stalling of Spliceosome Assembly at Distinct Stages by Small-Molecule Inhibitors of Protein Acetylation and Deacetylation

    JOBNAME: RNA 15#1 2009 PAGE: 1 OUTPUT: Tuesday December 9 15:25:03 2008 csh/RNA/175400/rna13326 Downloaded from rnajournal.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation ANDREAS N. KUHN,1 MARIA A. VAN SANTEN,1 ANDREAS SCHWIENHORST,2 HENNING URLAUB,3 and REINHARD LU¨ HRMANN1 1Department of Cellular Biochemistry, Max Planck Institute for Biophysical Chemistry, D-37077 Go¨ttingen, Germany 2Department of Molecular Genetics and Preparative Molecular Biology, Institute for Microbiology and Genetics, D-37077 Go¨ttingen, Germany 3Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, D-37077 Go¨ttingen, Germany ABSTRACT The removal of intervening sequences from a primary RNA transcript is catalyzed by the spliceosome, a large complex consisting of five small nuclear (sn) RNAs and more than 150 proteins. At the start of the splicing cycle, the spliceosome assembles anew onto each pre-mRNA intron in an ordered process. Here, we show that several small-molecule inhibitors of protein acetylation/deacetylation block the splicing cycle: by testing a small number of bioactive compounds, we found that three small-molecule inhibitors of histone acetyltransferases (HATs), as well as three small-molecule inhibitors of histone deacetylases (HDACs), block pre-mRNA splicing in vitro. By purifying and characterizing the stalled spliceosomes, we found that the splicing cycle is blocked at distinct stages by different inhibitors: two inhibitors allow only the formation of A-like spliceosomes (as determined by the size of the stalled complexes and their snRNA composition), while the other compounds inhibit activation for catalysis after incorporation of all U snRNPs into the spliceosome.
  • Structural Insights Into Nuclear Pre-Mrna Splicing in Higher Eukaryotes

    Structural Insights Into Nuclear Pre-Mrna Splicing in Higher Eukaryotes

    Downloaded from http://cshperspectives.cshlp.org/ on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Structural Insights into Nuclear pre-mRNA Splicing in Higher Eukaryotes Berthold Kastner,1 Cindy L. Will,1 Holger Stark,2 and Reinhard Lührmann1 1Department of Cellular Biochemistry, Max Planck Institute for Biophysical Chemistry, D-37077 Göttingen, Germany 2Department of Structural Dynamics, Max Planck Institute for Biophysical Chemistry, D-37077 Göttingen, Germany Correspondence: [email protected] SUMMARY The spliceosome is a highly complex, dynamic ribonucleoprotein molecular machine that undergoes numerous structural and compositional rearrangements that lead to the formation of its active site. Recent advances in cyroelectron microscopy (cryo-EM) have provided a plethora of near-atomic structural information about the inner workings of the spliceosome. Aided by previous biochemical, structural, and functional studies, cryo-EM has confirmed or provided a structural basis for most of the prevailing models of spliceosome function, but at the same time allowed novel insights into splicing catalysis and the intriguing dynamics of the spliceosome. The mechanism of pre-mRNA splicing is highly conserved between humans and yeast, but the compositional dynamics and ribonucleoprotein (RNP) remodeling of the human spliceosome are more complex. Here, we summarize recent advances in our understanding of the molec- ular architecture of the human spliceosome, highlighting differences between the human and yeast
  • Morphology, Behavior, and the Sonic Hedgehog Pathway in Mouse Models of Down Syndrome

    Morphology, Behavior, and the Sonic Hedgehog Pathway in Mouse Models of Down Syndrome

    MORPHOLOGY, BEHAVIOR, AND THE SONIC HEDGEHOG PATHWAY IN MOUSE MODELS OF DOWN SYNDROME by Tara Dutka A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland July, 2014 © 2014 Tara Dutka All Rights Reserved Abstract Down Syndrome (DS) is caused by a triplication of human chromosome 21 (Hsa21). Ts65Dn, a mouse model of DS, contains a freely segregating extra chromosome consisting of the distal portion of mouse chromosome 16 (Mmu16), a region orthologous to part of Hsa21, and a non-Hsa21 orthologous region of mouse chromosome 17. All individuals with DS display some level of craniofacial dysmorphology, brain structural and functional changes, and cognitive impairment. Ts65Dn recapitulates these features of DS and aspects of each of these traits have been linked in Ts65Dn to a reduced response to Sonic Hedgehog (SHH) in trisomic cells. Dp(16)1Yey is a new mouse model of DS which has a direct duplication of the entire Hsa21 orthologous region of Mmu16. Dp(16)1Yey’s creators found similar behavioral deficits to those seen in Ts65Dn. We performed a quantitative investigation of the skull and brain of Dp(16)1Yey as compared to Ts65Dn and found that DS-like changes to brain and craniofacial morphology were similar in both models. Our results validate examination of the genetic basis for these phenotypes in Dp(16)1Yey mice and the genetic links for these phenotypes previously found in Ts65Dn , i.e., reduced response to SHH. Further, we hypothesized that if all trisomic cells show a reduced response to SHH, then up-regulation of the SHH pathway might ameliorate multiple phenotypes.
  • Characterization of Purified Human Bact Spliceosomal Complexes Reveals Compositional and Morphological Changes During Spliceosome Activation and First Step Catalysis

    Characterization of Purified Human Bact Spliceosomal Complexes Reveals Compositional and Morphological Changes During Spliceosome Activation and First Step Catalysis

    Downloaded from rnajournal.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Characterization of purified human Bact spliceosomal complexes reveals compositional and morphological changes during spliceosome activation and first step catalysis SERGEY BESSONOV,1 MARIA ANOKHINA,1 ANDRIUS KRASAUSKAS,2 MONIKA M. GOLAS,2,4 BJOERN SANDER,2,5 CINDY L. WILL,1 HENNING URLAUB,3 HOLGER STARK,2 and REINHARD LU¨ HRMANN1 1Department of Cellular Biochemistry, MPI of Biophysical Chemistry, D-37077 Go¨ttingen, Germany 2Research Group of 3D Electron Cryomicroscopy, MPI of Biophysical Chemistry, D-37077 Go¨ttingen, Germany 3Bioanalytical Mass Spectrometry Group, MPI of Biophysical Chemistry, D-37077 Go¨ttingen, Germany ABSTRACT To better understand the compositional and structural dynamics of the human spliceosome during its activation, we set out to isolate spliceosomal complexes formed after precatalytic B but prior to catalytically active C complexes. By shortening the polypyrimidine tract of the PM5 pre-mRNA, which lacks a 39 splice site and 39 exon, we stalled spliceosome assembly at the activation stage. We subsequently affinity purified human Bact complexes under the same conditions previously used to isolate B and C complexes, and analyzed their protein composition by mass spectrometry. A comparison of the protein composition of these complexes allowed a fine dissection of compositional changes during the B to Bact and Bact to C transitions, and comparisons with the Saccharomyces cerevisiae Bact complex revealed that the compositional dynamics of the spliceosome during activation are largely conserved between lower and higher eukaryotes. Human SF3b155 and CDC5L were shown to be phosphorylated specifically during the B to Bact and Bact to C transition, respectively, suggesting these modifications function at these stages of splicing.